Family Medicine Doctors in Newport, VT Accepting Medicare

7 Family Medicine doctors found. Showing 1 - 7

Jessica Kathleen Andrews, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 189 Prouty Dr, Newport, VT 05855 Phone: 802-334-7331

Dr. John A Lippmann, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 186 Medical Village Dr, Newport, VT 05855 Phone: 802-334-3520    Fax: 802-334-3512

Dr. Mohammad Umair Malik, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 186 Medical Village Dr, North Country Primary Care, Newport, VT 05855 Phone: 802-334-4121

Patrick Keith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 186 Medical Village Dr, Newport, VT 05855 Phone: 802-334-3520

Dr. James Holcomb, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 81 Medical Village Dr, Newport, VT 05855 Phone: 802-334-4120    Fax: 802-334-4123

Allegra L Shumway, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 79 Coventry St, Newport, VT 05855 Phone: 802-334-5822

Denise Aileen Niemira, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 5452 U.s. Rt. 5, Ste. D, Newport, VT 05855 Phone: 802-334-6140    Fax: 802-334-8271

News Archive

Severely mentally ill have increased risk of death from coronary heart disease and stroke

A large British study indicates that individuals with severe mental illnesses are significantly more likely to die from coronary heart disease and stroke, but not cancer, than those without mental illnesses, according to a report in the February issue of Archives of General Psychiatry.

Advanced model reveals dynamic motions of SARS-COV-2 spike-shielding glycans

A recent paper published on the preprint server bioRxiv in September 2020 discusses the dynamic interactions of the spike protein glycan shield, which may be of great value in developing therapeutic compounds to fight severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Pathway Genomics introduces BRCA One for One program to detect breast and ovarian cancer

Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, today announced it has launched BRCATrueTM, a next-generation sequencing and deletion/duplication analysis that can detect mutations in BRCA1 and BRCA2, the genes linked to breast, ovarian and other types of cancer.

Gene therapy shows promise against dry mouth in cancer patients

Injecting an adenoviral vector encoding human aquaporin-1 into the parotid glands of head and neck cancer survivors improves their symptoms of dry mouth induced by radiation therapy, show study results.

Read more Medical News

› Verified 6 days ago